Can Cytokine Blocking Prevent Depression in COVID-19 Survivors?
Open accessThe claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The reduction degree of SII between admission and discharge forecasts relief of depression among coronavirus disease survivors.
“the reduction degree of SII between admission and discharge forecasts the relief of depression among coronavirus disease survivors (47).”
From Association between depression or anxiety symptoms and immune-inflammatory characteristics in in-patients with tuberculosis: A cross-sectional study (2022) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 6 · Cited by 55
- Authors
- Benedetti, F., Mazza, M., Cavalli, G., Ciceri, F., Dagna, L., & Rovere-Querini, P.
- Affiliations
- Vita-Salute San Raffaele University (IT)
- Corresponding author
- Benedetti, Francesco
- Venue
- Journal of Neuroimmune Pharmacology
- Published
- 2020-10-26
- Volume
- 16
- Issue
- 1
- Pages
- 1-3
- ISSN
- 1557-1890 (ISSN-L)
- 1557-1904
- PMC
- PMC7587545
- OpenAlex
- W3093708968
- Cited by
- 55
- References
- 6
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 9 · 2023: 13 · 2022: 12 · 2021: 15
- FWCI
- 2.97
- Type
- journal article
- Language
- en
- Update notices
- correction (2021-01-04)
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroimmune Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
- Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
- Keywords
- depression, COVID-19 survivors, post-COVID-19 depression, cytokines, neuroinflammation
- MeSH terms
- Cytokine Release Syndrome, COVID-19, Adult, Aged, Aged, 80 and over, Depression, Female, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Cytokines, Survivors, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
